XML 27 R16.htm IDEA: XBRL DOCUMENT v3.21.1
Basis of Presentation and Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Revenue by Source
The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):

Three months ended
March 31,
20212020
Royalties
Kyprolis$4,287 $4,405 
Evomela2,333 1,576 
Other492 584 
$7,112 $6,565 
Captisol$31,272 $21,109 
Contract revenue
Service Revenue$5,462 $3,357 
License Fees1,043 975 
Milestone8,417 334 
Other1,844 821 
$16,766 $5,487 
Total$55,150 $33,161 
Schedule of Short-Term Investments
Our short-term investments consist of the following at March 31, 2021 and December 31, 2020 (in thousands):
March 31, 2021December 31, 2020
Amortized costGross unrealized gainsGross unrealized lossesEstimated fair valueAmortized costGross unrealized gainsGross unrealized lossesEstimated fair value
     Bank deposits$51,232 $25 $(4)$51,253 $84,120 $35 $(1)$84,154 
     Corporate bonds25,853 72 (8)25,917 30,512 99 (1)30,610 
     Agency bonds4,501 — (4)4,497 4,499 — 4,501 
     Commercial paper19,815 — 19,824 45,459 27 (1)45,485 
     Corporate equity securities4,456 3,736 — 8,192 4,466 360 (1,388)3,438 
     Mutual fund151,830 53 — 151,883 151,512 386 — 151,898 
     Treasury bill— — — — 3,999 — — 3,999 
     Warrants— 1,422 — 1,422 — 393 — 393 
$257,687 $5,317 $(16)$262,988 $324,567 $1,302 $(1,391)$324,478 
     Viking common stock44,366 32,763 
     Viking warrants— 6,326 
Total short-term investments$307,354 $363,567 
Schedule of Available-for-Sale Debt Securities
The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):

March 31, 2021
Amortized CostFair Value
Within one year$77,913 $77,981 
After one year through five years23,488 23,509 
Total$101,401 $101,490 
Schedule of Goodwill and Other Identifiable Intangible Assets
Goodwill and other identifiable intangible assets consist of the following (in thousands):
March 31,December 31,
20212020
Indefinite-lived intangible assets
     Goodwill$190,515 $189,662 
Definite lived intangible assets
     Complete technology277,980 277,740 
          Less: accumulated amortization(67,441)(63,600)
     Trade name2,642 2,642 
          Less: accumulated amortization(1,345)(1,312)
     Customer relationships40,700 40,700 
          Less: accumulated amortization(16,264)(15,597)
     Contractual relationships362,000 362,000 
          Less: accumulated amortization(14,487)(7,243)
Total goodwill and other identifiable intangible assets, net$774,300 $784,992 
Schedule of Commercial License and Other Economic Rights
Commercial license and other economic rights consist of the following (in thousands):
March 31, 2021December 31, 2020
Gross
Adjustments(1)
NetGross
Adjustments(2)
Net
Aziyo and CorMatrix$17,696 $(9,530)$8,166 $17,696 $(9,588)$8,108 
Selexis and Dianomi10,602 (8,317)2,285 10,602 (7,731)2,871 
     Total$28,298 $(17,847)$10,451 $28,298 $(17,319)$10,979 

(1) Amounts represent accumulated amortization to principal of $11.9 million and credit loss adjustments of $6.0 million as of March 31, 2021.
(2) Amounts represent accumulated amortization to principal of $11.3 million and credit loss adjustments of $6.0 million as of December 31, 2020.
Schedule of Accrued Liabilities
Accrued liabilities consist of the following (in thousands):
March 31,December 31,
20212020
Compensation$3,347 $8,810 
Professional fees958 977 
Amounts owed to former licensees468 421 
Royalties owed to third parties102 693 
Return reserve682 687 
Acquisition related liabilities1,500 1,500 
Subcontractor1,034 733 
Supplier788 604 
Accrued interest1,086 464 
Other2,145 3,641 
     Total accrued liabilities$12,110 $18,530 
Schedule of Accounting for Share-Based Compensation The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):
Three months ended
March 31,
20212020
SBC - Research and development expenses$3,939 $2,397 
SBC - General and administrative expenses4,466 3,256 
$8,405 $5,653 
Schedule of Fair-Value Options Awarded to Employees and Directors
The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:

Three months ended
March 31,
20212020
Risk-free interest rate0.5%1.4%
Dividend yield
Expected volatility63%47%
Expected term5.04.7
Schedule of Computation of Basic and Diluted Earnings per Share
The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):
Three months ended
March 31,
20212020
Weighted average shares outstanding:16,435 16,529 
Dilutive potential common shares:
     Restricted stock112 — 
     Stock options701 — 
Shares used to compute diluted income per share17,248 16,529 
Potentially dilutive shares excluded from calculation due to anti-dilutive effect4,277 10,144